amiodarone has been researched along with Patency of the Ductus Arteriosus in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa Lopes, AA | 1 |
| Scalabrini Neto, A | 1 |
| Barbosa, SA | 1 |
| Tranchesi, J | 1 |
2 other studies available for amiodarone and Patency of the Ductus Arteriosus
| Article | Year |
|---|---|
Index of suspicion.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Cranial Nerve Neoplasms; Digoxin; Down Syndrome; D | 2002 |
[Wolff-Parkinson-White syndrome associated with morphology of complete left bundle branch block in a person with patent ductus arteriosus].
Topics: Amiodarone; Bundle of His; Bundle-Branch Block; Ductus Arteriosus, Patent; Electrocardiography; Hear | 1978 |